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On!83 at 9QVeP3 Ched paln (6 anlenCX 6 InfQnQf AMI) and rQStUd@d (4 hrs. 
(L 5 days) afler coronary artery mvascuIanZattQn therapy (acuta PTCA or 
rtPA4hrombctys~s) 18 (do) was rrmmmd fratm by frame w’!hm ragms of 
mlambt (21 * 21 ptxal) m normal .%-td rschemrc myocRrdrum and CVIEI (= 16 
onddtastQfa~lB @nds@~l13/fB Qndd~astds In 9$) was Mlculalafl. Success of 
wVascufttttzatlon therapy was delem~lned by Camncrry rtngmgraphy. reg,onal 
wall lttrkenint, and foltow.trp of myocafdml enzymes. 
f@u@s: CVIS war3 ei~i~nl~-~rea~~ in acvte inlarcmd myBoardlum 
in usrfpi3nscrt to normal m (8.8 f 7.6% vi3. 2Q 0 + 7.8s. p 5 0 001) 
kfwe reperhcwzn CVIB mcwwd stgndiicanlly tQ24.3 * 12.1% andzz.5 * 
lt.3%(4 hm. & Sday@wspt%ttve@)ver. n~rmtttvaluae(2l.B t 0.1% n.~ and 
23.3 + ?,5’%, n.r ) @Her @ucces?ful repetf~afon (8 pts-). WI@ did mt recover 
in 6 pts. with 12.3 z 2.Q% (4 hrs.. p 2 0.01) and 13.7 3 0.4*e (3 days. p Y 
0 05) m whom reperftmr~n lhempy was tmtt~cccsscf. 
C~&z%%t: CVlB detect@ tmmedtatety acute rnyccardral mfarctron and 
defmeatga eady beneftcral effects of coronary artery revasculanrabon ther. 
;:, 1058 1 BB TIMI emms ~ounl b Rspmdwlble Ouantitaliw 
Index of Coronary Ftuw? 
A. Hucenga. W R M Aengewerwn. T wan tier Weti, EW A. Vemey. 
Dew?wnt of CanHcgx Unw Hosprra~. ntfpegen. ??m Nemefkmis 
TM trar?‘te COunt (TFC) hJS been rwVdW?d ag a ofmple. repmdunbte 
quanfitatrve m&m of coronary fb tn aC\rte iny@card~ai mfarctian. TFC 1s 
based on the trme Interval. expressed m frames, between mmtlat appearance 
ot contrast tn Iti pmrrml ~rk39-y arsd its amat at wrtaln prespecdii drstal 
landmark?. 
To aMbr’C lnterobserver vanabrfrhy three Independent 0lpenonCed Jr’+ 
(pographer$ assessed TFC’s ot 30 coronary anenograms (10 LAD, 10 RCX. 
10 RCA) grvmg 60 dupto dewmunafsom. When presented In a hlslogram we 
noted that ICI about 60% of the cases Gaussran drstnbutron wtlh a &m&d 
dew~tm d about 3 frames was appmpna~e. In 20% however. consrderable 
r&agreement between observers exrsted. caused by ddterent mterprelafrcfn 
of the d&at larxfmark The Bfond-ARmon presentath?n showed thal thetr 
ddferences Mere arbrfranfy dcxnbuted (see betow). 
Cuncrumn. In fk% 010bsel~ahQnS TFC was a repmdvclbfe qUanhtalIv@ 
Index 01 coronary flow wnh a standard dewahon of 3 frames. In about 2tfa,. 
however. considerable dlscreparkxs occurred. ca~sat by uncenamty about 
&stat tandmark Kfenhlrcatlon for whtch a belter delrnitron IS needed. 
1058-151 hehospital AmbulancelBLead 
Electrocardiograms Reduce Door to Needle 
Time for Thrumbotysis in the Emergency Room 
P. DlLorenM. L. MarUn. lit. T. Mayer. M. Burke. E. Rubtno. M Sheridan.. 
lnslrhtte of Research and &ducatron, Irma Fam3r lfaspfal. Farfax 
Virgmia. USA 
6ackgmundr Rapid admrnlstralron of kbnnolylrc IhCrapy In eltgble acu(Q 
myocardlal inlarchon pattents confers a survival Improvement Prehospital 
12-lead EKGs should result m qurcker dlagnoscs of acute myocardlal Infare 
lion. Fairfax County Emergency Medical Servxes began mslallmg 1’2.lead 
EKG machines m their complement of ambulances begmning May 1996. 
We compare door-lo-needle bmes (DTNT) in conlemporaneous fibnnofyhc 
treated patients in one center. 
Meethods: Beginning December 1995. we prospecbvely analyzed 240 
consecutive fibrinolylrc treated patients at Fairfax Emergency Room ThtS 
group was compn’sed of 35 walk-in patients. 165 ambulance pabents wrfhouf 
prehospital 12-lead EKGs (AM - EKG). and 40 ambulance patients wrlh 
prenospital 12.lead EKGs (AM + EKG). There were no scgnificant baselrne 
differences between the groups. 
I B.A. &mown. S.R. Mcblechan. J. Allen. J. Anderson, A.A J. Adgey 
RegroMl Medrcaf Cardrology Cenfre, Royal Vrcfona !fosrzv?at d Unrwwsny of 
Ulster. Beftast. UK 
BacfgroUnd: Eady r@pertuBmn IS associated wrlh good pmgn~sn atter acp?e 
myucardrat rlarc%m (AMI) but arserrcnnent using 124ead ECG en&or txe 
chemlcat markers hae p- sihptlmal ras&ts Body wf~ce mappmg 
(BSM) ui~tlzes a much larger area of samplmng wrm spatral and temporal 
resott4ron. 
Melho&: &?nJt 64-tead antermr BSMs were recQIded from 67 patrents 
(ph) wttb AMt having coronary angrography 90 mms afler throm&ofylrc ther- 
apy BSMl was taken pflor IO. of Up to 65 mm:, after therapy (mean 18 mms 
f 5030). and Et%42 at 90-220 mtns (mean 124 mma T SD25) A drfference 
map (EtSMl-EtSM2) was constructed Fmm the 19tead ECG at the trme of 
ESMl. me maxrmurn ST ebvatron (STEmax) was notecf ~50% ST reso(u- 
non In ne same lead on ECG2 represented reperf~smn. The 67 pts wem 
mnd~@! dnn&?d ImO a tmW?g m Set (3 pls) Jnd b&dam (V) set (33 
ptsl Isomtegrat (area) and k30p&Ht~l ST-T vanabtes from drfterenc8 maps 
of Tset pts were compared fi TlMI ttow usmg a drscnmmant kmctron IO 
rdenbfy whrch vanables (24) best classrfwd reperfUxlon. A model co.nla~nmg 
these vanables was then tested pmspectrvely m the Wset. 
Ffesu/fs. RepertUsmn occurred m 3204 Ts-el pts (27 llM13.5 TlMl2) and 
29m Veer pts (25 TIM13 4 TIM&?). In the Tset. Use of STEmax resokrfron 
correctly classrfred 24i32 pts (senstirvrly 75%) who repectused and l/2 oc. 
ctuded pts (specrhcrty 50%) In the Vset. STEman resokmon classrfred ltd29 
pts (sensflnnty SY.) who reperfused and 214 occluded pts (spectfrrxty 50%) 
In companson. usrng ESMs. m the Tset me model conectfy classlhed all 
pts When tested m lhe Vset the model classfied 26129 pls who rep&used 
(sxtsrfway 97”,) and all 4 occluded prs (specifrcrly 10%). 
Cunc/usrorr~ BSM 6 a much more usehrt non+nvasrve tool than Ihe 12 
lead ECG n the assessment of reperfusron J*@r IhrumborVtlc lherapy for 
AMI 
and Left Ventricular 
Afte.r Direct PTCA: 
Comparison to Front-loaded rTPA 
G. P!zell~. C. Lu. 1. Shelban. A. Maqonalo. G. Vicedomm~. S.L. Chlerchrn 
RCCS H San Raftaele. Mrlano. /tafy 
6ackgmund. Compared lo thrombolysts (TL) dtrect cornnary nngroplasty 
(dPTCA) affords sgmflcant rmprovement tn acute patency rate. mortakty and 
posl-MI tschemlc evanij Arm ot our sludy was to compare the effects of 
dPTCA and TL on madual vrabrkty and regonal tunclmn recovery 
Methods. We studied 96 consecultve patients (pts) admitled wthrn 4 hours 
from th~ onset of symptoms for AMI. We excluded 20 pls wrlh no cleartif 
ST segment elevatfon and 6 w!lh zxdlogenrc shock Dt lno mmatnrng 70 pfs. 
32 undcrwenf dPTCA (gr 1) and 38 recerved front-loaded rTPA (gr 2) Aft 
underwent echocardtograms on admrssron. after 4 days dunng dobulamtne 
tnfuston (5-10-20 mcg.rkg/mtn) and al dacharge. For each pal!enl. we caf- 
culaled the dysfunctron score on adm!ssrOF (hypokmesla = 1. akmes!a = 2. 
d!skrnesca = 3) and tls percent reduclion after dobuterT!l~ (wabtfity) and at 
discharge (recovery). Gr.2 panents underwent elective F’TCA tnnfhm 7 dW. 
d the mfarct-related artery had more than 60?6 resrdual ster#1SiS. 
Res~/ts: On admlssion. there were no differences m age. sex. Site Of Mt. 
ttme fmm onser of symptoms. ST-segment elevatron (S 1: 20 t 11. gr.2 
18 + 6). dystunctron score (18 i 5 vs 16 z 6) and EF (47 2 10 vs 49 
f 9%). Thp delay from onset of symptoms and fmahnent was significanf@’ 
greater m gr.1 (144 = 96 vs 106 : g m!n. 2 C.C% Resulls were as 
follows: 
13~A AII,',;rRAC'I',~ .. P~ter  JACC l:chnta~' lqg~ 
i 
or1 gr2 p 
early repedusion (%) 100 70 NS 
lime ol CK pock (h,)ur~) 10 S I 3 tl t. 3 N8 
CK po~k (UI/I) 4307 t 3471 2449 t: 2137 -0,05 
vlllbltity (%) 3S L 20 40 .t 20% 0:07 
recovrm/(%) 16 :I: 20 03 ± 20% -;0,05 
Conch~,,~ions: Pie elected to PTCA have a granter likelihood of achieving 
early repodtmlen, However, In spite of that, percent mducllon of Infaml 
site ~nd the early recovery wore significantly lose tl~nn in pie undergoing 
thmmbolysls, Furthermore, we observed n trend towards lesser residual 
vl~bllty, The dol~y of treatment anent Is n critical factor which has to be 
carefully c0ostdomd bolero choosing dPTCA, A greater mpedusioo damage 
caused by abrupt mfl~w may also piny n role, 
Therapeutic Approaches for Myocardial 
P=chemla  
M o n d a y ,  M ~ r c h  30,  1998 ,  3 : 0 0  p , m , - 5 : 0 0  p ,m,  
G e o r g i a  Wor ld  C o n g r e s s  C e n t e r ,  W e s t  Exh ib i t  Ha l l  L e v e l  
Presen t~ , t ion  Hour :  4 : 0 0  p , m , - 5 : 0 0  p,m,  
~ ~  Beneficial Effects of Enhanced External 
Countorpulutlon (EECP) tony Not Be Mediated 
by Changes In Myoeardlal Peffualon 
R,R, Afore, O, Aklnboboye, M Slitter, J,-W, tin, P,J, Cannon, S, Borgmann, 
Ceh.nbia Unh,emltV, C o l l e ~  of Phy.~ieian~ ~ Sturgeons, New York, N'K, USA 
EECP hns boon reported to decrease iscltemic symptoms in patients with 
nnglnn l'Oflectoly to maximal medical therapy who are not candidates for 
mvascularitalien Howovet, the mochaniem nl the beneficial effecta el EECP 
am tlncloar, To evahiato lhe offool el EECP on myocardial pedu~ion, my- 
ocardial blond flow Was measured using PET in 11 patients befog end alter 
35 sessions of dolly EECP All 11 patients had anginl'l refractory to medlc~J 
therapy nnd hod failed pnor bypa,~o surgery nn~ltor comna~ interventions 
Patients worn studied nt met and aflor dipyodomote, and myocardial perfu. 
eton was quontlfind with 13NH3 and a 2,compartment malhomattcnl model, 
Them were no chongos in either hemodyn0~mlcs nor in the area of ischomia 
as ~ result of EECP, Although them was a decrease in nitroglycerin use and 
enhanced exercise tolerance alter EECP, myocardial blood Ilow at rest or 
after dipyridamoto was not different in either ischemic or infamtod zones (I) 
or in non.ischomic amos (NIl (oven though these tomtorios worn supplied by 
diseased corollary artonos as documented by their limited myocardial flow 
reserve in response to dipyridamole) 
R,):~I Hyporomla 
l NI l NI 
Pro-EECP 73(19~ 96(17) 9S (46) 17~ (74) 
Post-EECP 74 ~,~oi BS (20) 105 (41) 165 (66) 
V~tuos ~lm mean I~e) in mr100 g/mln 
The results 3uqgest them is no change in the region at risk nor in absolute 
myocardial portusion either at rest or during hyperomia early alter EECP 
therapy. Salutory responses to EECP thernpy may therefore be independent 
el =Is effects on myocardial peffusion. 
I 1 0 5 9 - 1 3 2  ] Long - te rm  E v o l u t i o n  o f  Severe Th ree -vesse l  
C o r o n a r y  A r t e r y  D isease Not  A m e n a b l e  t o  
Revascularlzatlon 
I. Shoiban, G. Fragasso, S, Tonni, P. Pagnotta, S.L. Chierchia. IRCCS H 
San Raf~ele. Milano, Italy 
Myocardial revasculantation exerts favourable effects on prognosis and qual- 
ity ot life in patients (pts) with severe coronary artery disease (CAD). Aim 
of this study was to assess survival and quality of lile in pts with diffuse 
CAD, not eligible for revascularization From a retrospective analysis of 1100 
pts undergoing diagnostic cardiac catheterization for angina pectods, we 
selected 64 pts (5.8%-59 males, mean age 55.3 years, range 39-66) with 
diffuse CAD None of the pts underwent ~ny revascularization procedure, all 
were discharged on full medical therapy and to,owed-up for an average time 
of 101.3 months (range 36-184). For study purposes we correlated angina 
type. presence/absence of previous myocardial infarction (MI), ejection frac- 
tion (EF) and magnitude of left ventricular (LV) wall motion abnormalities 
(WMA) with event.hoe survival. At the end of monitoring, 60.2% of pts was 
alive, of whom 333% was asymptomatic, 31% had improved symptoms and 
35 7°0 without changes in symptoms severity. Survival was 46% and 84.2% 
in pts with/without previous MI (p = 0,004), EF .~ 50% was present in 78,6% 
of asymptomatle pts, 92.3% of those with reduced symptoms and 66.7% of 
those with unchanged symptoms, 21,4% end 45,5% of surviving/not surviv- 
ing pte had an EF .- 50% (p = 0,026), Survival was 76,P/c, in pts wlth normal 
LV function or localized hypoklnosia, 53,5% of those with diffuse hypokinosia 
nnd/or localized aklnesln, nnd 42,8% of pts with LV nnoun/sm, 
In r, oncluslon, LV function Is confirmed as the most Important progoostic 
factor In patients with aovore CAD, The high prevalence of pie with m. 
ducod/absent symptoms end the good survival rate might be due to currently 
improved therapeutic ntrntegtes nnd/or to an unintentional prevalence o! pts 
with good global LV function included in our study, 
• Results of Pereutaneoua Intervention for 
Unprotected Left Main Coronary StQnoaea In 
S u r g l e M  and  Non-aurg!©a!  C ~ . d ! d M e e  
T, Plokker, K, Kosttga, S,-J, Park, H Tamsi, U Sigwart, S, EIIis, St Antomus 
Zmkenhui,~, The Neth~rlnnd~ 
Both stealing iS) ~lnd directional athem~fomy (DCA) have re~ent!y t~en pro. 
posed as mnsonab!e Ntematives to CABG for patients (pts) with unprotected 
loll main stenosos (ULMS) To ascertain m!t~mes for pta at different CABG 
ask we quened e, mglsmj at 22g consecutively treated non acute MI pts 
treated nt 25 centers since t ~4, Angles were cam lab reviewed with 75% 
!~lO fellow up, 13% of inoperable ple had cancer or other tile.limiting illness. 
USUal IR=sk High R isk  Inol~table 
n l t9 ~ 31 
AOO (vrs! 62 t 12 73 = 14 69 t t i  
LVEF (%) 50 t 10 45, ~ 15= 41 ~ 18, 
Rosl;pmgr engm~ (%l 286 45 8 67 7 
Stoat (%) 64 1 ; 1 ~ 71 O 
DCA (%) .~6 9 t6 7 3 2 
In,hosplhlt 
Cardiac d~th (%1 17 102 19 4 
QMI (%t O 8 I 8 6 7 
Em CABG t%) 0 e O O 0 O 
tlestenosts (",,) 23 3 269 50 O 
t0 month do,'tlh (%l ? 4 20 9 57 t 
12 monlh dentil, MI or GAnG i%t 19 O 33 t 59 4 
Clinical vanables strongly influence outcome el percutaneous tpere) rx ot 
ULMS, Pore rx may be reasonable m some settings, although the 5.7% el 
post-dischargo doeth at 12 rues. tot usual nsk pts is womsome. 
~ Effect of Standard Anti-lschemic Therapy on 
A n g i n a l  Episodes in Patients Wi th  S y n d r o m e  X 
v, Pascon, G. Colonna, C, Iorardh R. Natah, D, Fischettl, A Mason, 
GA, Lanza. Istituto di Cardtotogla, Universit.~ Cattolica dot SL Cuom. Rome. 
Italy 
Since patients (pts) with syndrome X (SX, angina, normal coronas/artenes. 
ischemia-liko ECG changes on exercise testing) have a good long term prog- 
nosis, the only aim of treatment is the reliel of symptoms. Yet, no previous 
study has directly compared th,3 effect e! standard anti-ischemic drugs on the 
frequency o! anginal episodes in these pts. Thus, we pedormed a double- 
blind, controlled, crossover thai on the effects of conventional anti-ischemtc 
therapy (beta-blockers, calcium-antagonists, nitrates) on anginal symptoms 
in 10 pts (57 ± 7 years, 4 men) with SX, who had - 3  anginal episodes per 
week. After a 4-week run-in period, pts were treated with either amlodipine 
(AML, 10 mg), isosorbide 5-mononitrate (ISMN, 40 rag), or atenolol (ATEN, 
100 mg), given once a day tm a penod of 4 weeks each, in a randomised 
cross-over order. Pts reported the occurrence of anginal episodes on an 
appropriately structured diary. Quality of life was assessed through a visual 
analogic scale (0 to 100 ram). A significant improvement or worsening was 
defined as a reduction or an increase of ~ 25°o of anginal episodes compared 
to run-in. The main results are summadzed in the table. 
Run-in ISMN AML ATEN 
Anginal episodes 23 -, 18 24 i 22 21 ,~ 22 15 ~ 13" 
Quality of lifq 22 ~ 16 30 :t 27 51 ± 25" 59 :~ 29" 
Pts improved 4 5 6 
Pts worsened 3 3 0 
• P • e OS VS run-in 
Thus, our data suggest that beta-blockers are, on average, more effective 
than ether classic antiischemic drugs in controlling anginal episodes in SX 
pls. 
